Cardiomyopathy Trial, Recruiting NCT04990297 Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT04990297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose heart is not pumping blood as strongly as normal (the heart's pumping function is measured at less than 50%)
  • People whose heart's main pumping chamber is larger than the normal range for their body size and age

Who may not be able to join:

  • People with any signs of blocked heart arteries (ischemic heart disease), including results from artery imaging, blood flow scans, a specific scarring pattern seen on heart MRI scans, or a history of heart attack or procedures to open blocked arteries
  • People with a condition where the heart muscle is abnormally thick (hypertrophic cardiomyopathy), moderate to severe heart valve problems, or diseases where abnormal substances build up in the heart (such as amyloidosis, sarcoidosis, or Fabry disease)
  • People with constant, uncontrolled irregular heart rhythms
  • People who are unable to lie flat
  • People who are pregnant
  • People for whom an MRI scan would not be safe, including those with severe claustrophobia, an implanted defibrillator or pacemaker, certain types of metal clips in the brain, metal fragments in the eye, or advanced kidney disease (Stage IV or V)
  • People with diabetes that has caused damage to other organs in the body
  • People who are unable to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Minjie Lu, PhD, Chinese Academy of Medical Sciences, Fuwai Hospital

Phone: +86-10-88396941

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Registry
ClinicalTrials.gov
Start date
24 December 2019
Est. completion
31 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

All-cause Mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov